Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia

Journal of Experimental Medicine

Volumn 184, Issue 5, 1996, Pages 1601-1608

  Pajkrt, D ^a,d   Doran, J E ^b   Koster, F ^a   Lerch, P G ^b   Arnet, B ^b   Van Der Poll, T ^a,c   Ten Cate, J W ^a   Van Deventer, S J H ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Central Laboratory in Bern   (Switzerland)

^c ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD14 ANTIGEN; CD18 ANTIGEN; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR;

ADULT; ANTIGEN EXPRESSION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENDOTOXEMIA; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SEPSIS;

EID: 0029829525     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.184.5.1601     Document Type: Article

References (30)

1. Ziegler-Heitbrock, H.W.L., and R.J. Ulevitch. 1993. CD14: Cell surface receptor and differentiation marker. Immunol. Today. 14:121-125.
2. Frey, E.A., D.S. Miller, T. Gullstein Jahr, A. Sundan, V. Bazil, T. Espevik, B.B. Finlay, and S.D. Wright. 1992. Soluble CD14 participates in the response of cells to lipopolysaccharide. J. Exp. Med. 176:1665-1671.
3. Tobias, P.S., K. Soldau, J.A. Gegner, D. Mintz, and R.J. Ulevitch. 1995. Lipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD14. J. Biol. Chem. 270:10482-10488.
4. Wright, S.D., R.A. Ramos, A. Hermanowski-Vosatska, P. Rockwell, and P.A. Detmers. 1991. Activation of the adhesive capacity of CR3 on neutrophils by endotoxin: dependence of lipopolysaccharide binding protein and CD14. J. Exp. Med. 173:1281-1286.
5. Ulevitch, R.J., and P.S. Tobias. 1995. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu. Rev. Immunol. 13:437-457.
6. Wurfel, M.M., S.T. Kunitake, H. Lichenstein, J.P. Kane, and S.D. Wright. 1994. Lippolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS. J. Exp. Med. 180:1025-1035.
7. Wurfel, M.M., E. Hailman, and S.D. Wright. 1995. Soluble-CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein. J. Exp. Med. 181:1743-1754.
8. Emancipator, K., G. Csako, and R.J. Elin. 1992. In vitro inactivation of bacterial endotoxin by human lipoproteins and apolipoproteins. Infect. Immun. 60:596-601.
9. Flegel, W.A., A. Wölpl, D.A. Männel, and H. Northoff. 1989. Inhibition of endotoxin-induced activation of human monocytes by human lipoproteins. Infect. Immun. 57:2237-2245.
10. Read, T.E., H.W. Harris, C. Grunfeld, K.R. Feingold, J.P. Kane, and J.H. Rapp. 1993. The protective effect of serum lipoproteins against bacterial lippolysaccharide. European Heart J. 14(Suppl.):125-129.
11. Baumberger, C., R.J. Ulevitch, and J.M. Dayer. 1991. Modulation of endotoxin activity of lipopolysaccharide by high-density lipoprotein. Pathobiology. 59:378-383.
12. Harris, H.W., C. Grunfeld, K.R., Feingold, and J.H. Rapp. 1990. Human VLDL and chylomicrons can protect against endotoxin induced death in mice. J. Clin. Invest. 86:696-701.
13. Feingold, K.R., J.L. Funk, A.H. Moser, J.K. Shigenaga, J.H. Rapp, and C. Grunfeld. 1995. Role of circulating lipoproteins in protection from endotoxin activity. Infect. Immun. 63: 2041-2046.
14. Levine, D.M., T.S. Parker, T.M. Donelly, A. Walsh, and A.L. Rubin. 1993. In vivo protection against endotoxin by plasma high density lipoprotein. Proc. Natl. Acad. Sci. USA. 90:12040-12044.
15. Parker, T.S., D.M. Levine, J.C.C. Chuang, J. Laxer, C.C. Coffin, and A. L. Rubin. 1995. Reconstituted high-density lipoprotein neutralizes gram-negative bacterial lipopolysaccharides in human whole blood. Infect. Immun. 63:253-258.
16. Doran, J.E., P. Lerch, and A.P. Hubsch. 1994. Natural and artificial lipoproteins modulate lipopolysaccharide-induced tumour necrosis factor production in vitro and in vivo. Old Herborn University Seminar Monographs 5: 106-121.
17. Hubsch, A.P., F.S. Powell, P.G. Lerch, and J.E. Doran. 1993. A reconstituted, apolipoprotein A-1 containing lipoprotein reduces tumor necrosis factor release and attenuates shock in endotoxemic rabbits. Circ. Shock. 40:14-23.
18. Cué, J.I., J.T. Di Piro, L.J. Brunner, J.E. Doran, M.E. Blankenship, A.R. Mansberger, and M.L. Hawkins. 1994. Reconstituted high-density lipoprotein inhibits physiologic and tumor necrosis factor α responses to lipopolysaccharide in rabbits. Arch. Surg. 129:193-197.
19. Quezado, Z.M.N., C. Natanson, S.M. Banks, D.W. Alling, C.A. Koev, R.L. Danner, R.J. Elin, J.M. Hosseini, T.S. Parker, D.M. Levine et al. 1995. Therapeutic trial of reconstituted human high-density lipoprotein in a canine model of Gram-negative septic shock. J. Parmac. Exp. Therapeut. 272: 604-611.
20. Lerch, P.G., V. Förtsch, G. Hodler, and R. Bolli. 1996. Production and characterization of a reconstituted high density lipoprotein (rHDL) for therapeutic applications. Vox Sang. 71:155-164.
21. Sturk, A., K. Joop, J.W. ten Cate, and L.L.M Thomas. 1985. Optimalization of a chromogenic assay for endotoxin in blood. In Bacterial Endotoxins: Structure, Biomedical Significance, and Detection with the Limulus Amebocyte Lysate Test. J. W. ten Cate, H.R. Büller, A. Sturk ,and J. Levin, editors. Alan R. Liss, Inc., New York. 117-136.
22. Mészáros, K., S. Aberle, M. White, and J.B. Parent. 1995. Immunoreactivity and bioactivity of lipopolysaccharide-binding protein in normal and heat-inactivated sera. Infect. Immun. 63:363-365.
23. Van Deventer, S.J.H., H.R. Büller, J.W. ten Cate, L.A. Aarden, C.E. Hack, and A. Sturk. 1990. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood. 76:2520-2526.
24. 23). J. Infect. Dis. 172:144-151.
25. Eggesbo, J.B., I. Hjermann, A.T. Høstmark, G.B. Joø, and P. Kierulf. 1993. Lipopolysaccharide-induced monocyte procoagulant activity, fibrinopeptide A, and PAI-1 levels in persons with high or low levels of HDL-lipoprotein. Thromb. Res. 70: 161-171.
26. Marchant, A., J. Duchov, J.P. Delville and M. Goldman. 1992. Lipopolysaccharide induces up-regulation of CD14 molecule on monocytes in whole blood. Eur. J. Immunol. 22: 1663-1665.
27. Bazil, V., and J.L. Strominger. 1991. Shedding as a mechanism of down-modulation on stimulated human monocytes. J. Immunol. 147:1567-1574.
28. Wright, S.D., R.A. Ramos, P.S. Tobias, R.J. Ulevitch, and J.C. Mathison. 1991. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science (Wash. DC). 252:1321-1322.
29. Arfors, K.E., C. Lundberg, L. Lindbom, K. Lundberg, P.G. Beatty, and J.M. Harlan. 1987. A monoclonal antibody to the membrane glycoprotein complex CD18 inhibits polymorphonuclear leukocyte accumulation and plasma leakage in vivo. Blood. 69:338-340.
30. Eichacker, P.Q., A. Farese, W.D. Hoffman, S.M. Banks, T. Mougins, S. Richmond, G.C. Kuo, T.J. Macvittie, and C. Natanson. 1992. Leukocyte CD11b/18 antigen-directed monoclonal antibody improves early survival and decreases hypoxemia in dogs challenged with tumor necrosis factor. Am. Rev. Respir. Dis. 145:1023-1029.